Astellas Pharma Donates $2 Million
About 75 percent of women with obstetric fistula have gone through labor that has lasted three days or more. Obstetric fistula affects mostly the poorest women who live in the poorest countries of the world because they do not have access to proper medical help. When a woman’s labor is obstructed she most likely could have intense pain for days before she actually has the baby.
So what exactly is an obstetric fistula?
“The soft tissues between the baby’s head and the pelvic bone are compressed and do not receive adequate blood flow … Her baby likely dies and she is often left with obstetric fistula, a small hole created by constant pressure from the fetus, which renders her incontinent.”
An estimated one million women get obstetric fistula and only 20,000 of those get treated a year. The surgery that these women would need takes under an hour and costs around $450. The need is there for these women to receive medical help and that is why Astellas Pharma EMEA decided to dedicate $2 million to help the cause.
Over the course of three years, Astellas will be partnered with the Fistula Foundation and put that $2 million to work. This is believed to be the largest and most focused effort ever against fistula according to Kate Grant, CEO of the Fistula Foundation.
The money will allow 1,200 women to get surgery in Kenya for this life-changing condition. As part of Astellas heritage, one of the key things that this organization wants to bring to communities is hope.
“Astellas knows the difference good medicines make to peoples’ lives. That‘s why we focus on providing treatments that are a genuine advance on the current standards of care – particularly in disease areas where options are limited.”
Here in the United States, the obstetric fistula was a common term that most people knew about, until the early 20th century. Since the U.S. has the resources for great medical care, there are procedures like a cesarean section, that we can use to prevent fistula. Kenya doesn’t have what the U.S. does, so companies like Fistula Foundation and Astellas are doing something about it.
– Brooke Smith
Sources: ONE, Astellas, Fistula Foundaiton